4-Methylumbelliferone (4-MU)

4-Methylumbelliferone (4-MU)

Catalog Number:
L002371368APE
Mfr. No.:
APE-B6001
Price:
$196
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          IC50: 0.4 mM4-Methylumbelliferone is a hyaluronic acid (HA) synthesis inhibitor. The activation of HAS2 and the over-production of HA are existed in many metastatic tumor cell lines. Increased synthesis of HA is often associated with increased metastatic potential and invasivity in tumor cells.In vitro: 4-Methylumbelliferone (MU), an inhibitor of HA synthesis, has been studied as a potential anti-tumor drug on account of inhibiting the growth of primary tumors and distant metastasis of tumor cells. The mechanism still needs to be clarified, although several studies revealed that the anticancer effects of MU are mediated by inhibition of HA signal pathway. In a previous study the regulation of HA synthesis was demonstrated by ceramide, and now show how MU activated NSMase2 generates ceramides and mediates MU modulated inhibition of HA synthesis (cell migration and invasion, and apoptosis of tumor cells). Using a HA enriched mouse oligodendroglioma cell line G26-24, it was found that MU elevated the activity of NSMase2 and enhanced ceramide levels, which in turn potentiated phosphatase PP2A activity. Further, the activated PP2A decreased phosphorylation of Akt, reduced activities of HA synthase2 (HAS2) and calpains, and blocked both the synthesis of HA, and the migration and invasion of G26-24 tumor cells. In addition, MU mediated ceramide induced activation of p53 and caspase-3, decreased SIRT1 expression and deduced G26-24 viability. The mechanism of the MU anticancer therefore initially involves NSMase2/ceramide/PP2A/AKT/HAS2/caspase-3/p53/SIRT1 and the calpain signaling pathway, indicating that ceramides play a important role in the ability of a tumor to become aggressively metastatic and grow [1].In vivo: So far, no study in vivo has been conducted.Clinical trial: Clinical study has been conducted.

      • Properties
        • Alternative Name
          7-hydroxy-4-methyl-2H-chromen-2-one
          CAS Number
          90-33-5
          Molecular Formula
          C10H8O3
          Molecular Weight
          176.17
          Appearance
          A solid
          Purity
          99.88%
          Solubility
          insoluble in H2O; ≥2.45 mg/mL in EtOH with gentle warming and ultrasonic; ≥8.8 mg/mL in DMSO
          Storage
          Desiccate at -20°C

          * For Research Use Only

    We Also Recommend

    SB273005

    $335

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.